Laid off in Boston in 2026: what is actually happening, and what your skills are still worth.

Boston's labor market is shaped by three dominant clusters: biotech and pharma along Kendall Square and the 128 corridor, financial services led by Fidelity and State Street, and a deep university and hospital system stretching across the metro. Tech and SaaS — HubSpot, Wayfair, Toast, DraftKings, a long list of smaller firms — sit alongside the others. The 2024–2026 wave has hit biotech harder than the rest. Venture funding for early-stage biotech contracted sharply after 2022, and the cuts have run through both clinical-stage companies and the larger pharma firms with Boston operations. Tech cuts at HubSpot, Wayfair, and others have followed the national pattern. Finance has trimmed selectively. Higher education and the hospital systems have been the most stable employers in the metro. What that means: a laid-off biotech professional is facing a tighter local market than they were used to, and the path forward often involves either a larger pharma employer with a Boston footprint, a pivot into health-tech or medical devices, or a willingness to consider out-of-state roles. A laid-off tech worker has more local options than they might think — the hospital systems and biotech firms hire software, data, and product talent.

What your skills are still worth

Your skills did not disappear with the role.

Computational biology, bioinformatics, and clinical data work: Early-stage biotech is compressed, but the larger pharma firms, the hospital research operations, and the growing pool of health-AI startups are all hiring quantitative life-sciences talent. The combination of bio domain knowledge and modern data tooling is one of the shortest searches in the Boston metro.
Regulatory, clinical operations, and quality experience: If you have worked in clinical trial operations, regulatory affairs, or quality at a biotech or pharma, the market is steady. Larger pharma employers, contract research organisations, and medical-device firms are all hiring this profile, and the skills are not easily replaced.
Software engineering applied to healthcare, biotech, or finance: Engineers with experience at a Boston tech firm transfer cleanly into health-tech, biotech IT, and the local financial firms. Fidelity, State Street, MassMutual, and the hospital systems all hire backend, platform, and data engineers, often with shorter loops than tech-only employers.
Product management for technical or regulated products: Generalist PMs are facing the same compression as elsewhere. PMs who can credibly ship in a regulated environment — health, finance, devices, scientific tooling — are landing offers across the metro.
Operations and program management in scientific or regulated settings: Operations leads who have run a lab, a clinical program, a regulated product launch, or a complex hospital initiative are in demand at biotech, devices, hospital systems, and health-tech firms.

Role-specific paths from here

Where each role goes next.

From: Scientist or research associate at a clinical-stage biotech that just cut: Scientist role at a larger pharma firm with a Boston operation (Takeda, Sanofi, Novartis, Pfizer)
Scientific role at a contract research organisation or scientific tooling company
Computational role at a health-AI or bioinformatics company
From: Operations or program manager at a Boston biotech post-cut: Clinical operations or program role at a larger pharma or CRO
Operations role at a medical-device or scientific instruments firm
Program manager role at a hospital system, research institute, or health-tech company
From: Software engineer at a Boston tech employer that just cut: Engineer at a Boston health-tech or biotech IT team
Engineer at Fidelity, State Street, MassMutual, or another regional financial firm
Engineer at a hospital system modernising its tooling (Mass General Brigham, Beth Israel Lahey)
From: Product or marketing role at a SaaS company in the metro: PM or marketer at a health-tech, biotech IT, or scientific tooling company
Product role at a Boston financial services firm
Marketing role at a B2B SaaS still hiring in the metro (or a remote-first equivalent)

Questions

Common questions

Is the Boston biotech downturn over?

Not entirely. Early-stage biotech funding has improved from its 2023 low but has not returned to 2021 levels, and many smaller companies are still running cautious. Larger pharma employers and CROs are the more stable buyers and have absorbed a portion of the laid-off scientific workforce. If you were at a clinical-stage company that ran out of runway, the realistic plan is to widen the search beyond similar-stage employers.

What if I want to leave biotech entirely after a layoff?

Boston is one of the better metros to do this from. The same skills that produce work in biotech transfer into health-tech, medical devices, scientific tooling, hospital operations, and a small but growing AI-in-life-sciences sector. The pivot is real and people do it every year — the misconception is that you have to leave science to leave biotech.

Are the universities and hospitals hiring through the layoffs?

Yes, broadly. Mass General Brigham, Beth Israel Lahey, and the major universities have not run the kind of corporate cuts the biotech and tech sectors have. The pay is lower than industry but the stability is real, and the benefits are usually better. For people coming out of a third or fourth biotech cut, an academic medical center or research institute role is often the steadiest move available.

How does Boston cost of living affect a long search?

Boston rent and housing are high but generally more sustainable than NYC or the Bay Area for a six-month search, especially outside the inner core. The biggest risk is healthcare — COBRA from a biotech or tech employer can be expensive. Massachusetts has its own subsidised marketplace (the Health Connector), which is often cheaper than COBRA and worth comparing before signing up.

Your plan is built around what you tell us — not a template.

Start with a few questions. The plan follows.

Start your plan

Less than one session with a career coach.